showed that miR-139-5p is downregulated in GBC and that low expression is associated with poor prognosis; they further identified pyruvate kinase M2 (PKM2) as a direct target, and restoration of miR-139-5p reduced PKM2 expression, glycolytic flux and tumour growth. This evidence concerns the gene PKM and neoplasm.